|

Rivaroxaban 15 MG Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 4: 2

Top Sponsors

  • Korea University Anam Hospital1
  • Instituto Nacional de Cardiologia Ignacio Chavez1

Indications

  • Heart Disease2
  • NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)1
  • Coronary Artery Ectasia1
  • Acute Coronary Syndromes (ACS)1
  • STEMI - ST Elevation Myocardial Infarction1

Other2 trials

Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
Phase 4
Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.